Prophylactic use of zoledronic acid to prevent early bone loss is safe and feasible in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation

✍ Scribed by Siddhartha Ganguly; Clint L. Divine; Omar S. Aljitawi; Sunil Abhyankar; Joseph P. McGuirk; Leland Graves

• Book ID: 115092127
• Publisher: John Wiley and Sons
• Year: 2011
• Tongue: English
• Weight: 284 KB
• Volume: 26
• Category: Article
• ISSN: 0902-0063
• DOI: 10.1111/j.1399-0012.2011.01527.x